Medicines / Novo Nordisk India / Xultophy
XultophyInsulin Degludec + Liraglutide
Xultophy is marketed by Novo Nordisk India. 1 pack on NPPA's price list for July 2026, containing Insulin Degludec + Liraglutide.
- Packs listed
- 1
- Lowest MRP
- ₹5,377
- Per unit
- ₹1,792
- Price-controlled packs
- 0 of 1
- Dosage forms
- 1
Packs and prices
- ₹5,377Xultophy 100 Iu/3.6 mg Injection 3 mlInsulin Degludec + Liraglutide Injection 100 Iu/3.6 mg · ₹1,792 per ml
The company
Novo Nordisk India has 66 packs on the price list. Company record
Prices are the maximum retail prices each company filed with the National Pharmaceutical Pricing Authority (NPPA) for July 2026, read from NPPA's Pharma Sahi Daam service on 2 Oct 2026. A price in a shop can be lower; it may not lawfully be higher. Failed batches are those CDSCO and state laboratories declared not of standard quality. This is a record of prices and filings, not medical advice: do not change a medicine without your doctor or pharmacist. Source: NPPA and CDSCO, Government of India. About this record.